NCT06492616
Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT06492616
Title A Study of Elacestrant Versus Standard Endocrine Therapy in Women and Men With ER+,HER2-, Early Breast Cancer With High Risk of Recurrence (ELEGANT)
Acronym ELEGANT
Recruitment Active, not recruiting
Gender both
Phase Phase III
Variant Requirements No
Sponsors Stemline Therapeutics, Inc.
Indications
Therapies
Age Groups: adult | senior
Covered Countries USA | TUR | ROU | POL | NLD | ITA | HUN | GBR | FRA | FIN | ESP | DNK | DEU | CZE | CHE | CAN | BRA | BEL | AUT | AUS | ARG


No variant requirements are available.